RecruitingNCT05839418
Sustained Effort Network for Treatment of Status Epilepticus/European Academy of Neurology Registry on Refractory Status Epilepticus (SENSE-II/AROUSE)
Sponsor
Erasme University Hospital
Enrollment
3,000 participants
Start Date
Mar 1, 2023
Study Type
OBSERVATIONAL
Conditions
Summary
SENSE-II/AROUSE is a prospective, multicenter registry for patients treated for SE. The primary objective is to document patients and SE characteristics, treatment modalities, EEG features, and outcome of consecutive adults admitted fir SE treatment in each of the participating centers and to identify predictors of outcome and refractoriness.
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Patients aged 18 years or above
- Patients admitted for management of Status Epilepticus as their primary diagnosis
- Patients admitted for another primary diagnosis but identified with Status Epilepticus during their acute hospital stay
Exclusion Criteria1
- \- Patients with post-cardiac arrest SE
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05839418
Related Trials
Simulation Trial of Telemedical Support for Paramedics
NCT064417609 locations
Recovery Trajectory for Coma and Disorders of Consciousness
NCT076140741 location
Study of Pathophysiology of Status Epilepticus and Dysimmune Encephalitis
NCT044218461 location
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
NCT0690717352 locations
EEG Monitoring for Refractory Status Epilepticus
NCT041704911 location